ANSWERS TO COMMON FITNESS QUESTIONS

We all have fitness questions, whether we’re new to working out or have been at it for a while. Here are the answers to some common fitness questions.  How Often Should I Work Out?  Everyone should commit to working out a minimum of three days a week to see results. The American College of Sports Medicine recommends a minimum of 150 minutes of high-intensity cardio, 75 minutes of vigorous-intensity exercise or a combination of moderate and vigorous-intensity exercise per week.

….FULL ARTICLE

EXERCISE: THE KEY TO A LONG LIFE

Do you want to live a long and healthy life? Be strong and agile as you age? Enjoy life into your 90s?  The key to a lengthy, prosperous life is exercise. No matter your age – whether you’re 16 or 65 – you should begin now with an exercise program or step up the one you already have. Studies have shown exercising on a regular basis is part of a healthier and more rewarding senior life. Staying active may affect how long you live and how energetic and vital you remain. Exercise provides a kind of health insurance.

….FULL ARTICLE

THE KNOWLEDGE TO BUILD A BETTER BODY

Kevin Balcirak is not playing around when it comes to fitness and health.

For the past 20 years, Balcirak (pronounced Ball-sir-rack) has owned and operated Body Structure in Lexington. While a 5-second Google search will yield a long list of gyms in the Bluegrass, Body Structure among them, Balcirak’s concept is quite different from the rest.

….FULL ARTICLE

Use the buttons below to scroll through more great articles on health and wellness issues

MORE ARTICLES

Be Sociable, Share!

Share on Facebook Share on Twitter Share on Delicious Share on Digg Share on Google Bookmarks Share on LinkedIn Share on LiveJournal Share on Newsvine Share on Reddit Share on Stumble Upon Share on Tumblr

MORE FEATURE ARTICLES

CONTACT INFORMATION

© Health & Wellness Magazine - All rights reserved | Design by PurplePatch Innovations

MORE FROM ROCKPOINT PUBLISHING

HEALTH & WELLNESS MAGAZINE

HOME | FEATURE ARTICLES | COLUMNS | DIGITAL ISSUES | CALENDAR | DIRECTORY | ABOUT | CONTACT

subscribe to Health & Wellness


The results of two new randomized and controlled mental health research studies demonstrated that just one dose of psilocybin produces significant long-term improvements in patients with anxiety and depression. These findings, recently published in The Journal of Psychopharmacology, are potentially beneficial for individuals who are troubled by anxiety and depression.


Psilocybin is a hallucinogenic substance obtained from certain types of mushrooms indigenous to tropical and subtropical regions of South America, Mexico and the United States. Fifty-one adults participated in the double-blind crossover study at Johns Hopkins University. New York University was the second site. Stephen Ross, M.D., principal investigator of the NYU study and director of substance abuse services in the Department of Psychiatry at Langone Medical Center, said all patients received targeted counseling plus a 0.3 mg/kg dose of psilocybin at one of two treatment sessions. A vitamin placebo at the other session realized 80 percent of the subjects experienced a significant reduction in anxiety and depressive symptoms after six months. Furthermore, 80 percent of the subjects realized clinically significant decreases in symptomology six months after their final treatment session, suggesting there may be longer term benefits with less need for medication.


Further research with larger samples needs to be conducted,

INNOVATIVE RESEARCH FINDINGS SUGGEST NEW DIRECTION IN MENTAL HEALTH CARE

but it is clear these initial findings raise the issue that psilocybin holds true potential for treating anxiety and depression in patients with this diagnosis. These results represent a dramatic step forward in the mental health profession’s efforts to help some of the most seriously affected patients needing a more effective protocol of care and treatment for anxiety and depression.


Sources and Resources:


•  Hallucinogenic drug psilocybin eases existential anxiety in people with life threatening cancer. Baltimore, MD: Johns Hopkins University School of Medicine; December 1, 2016.

•  Single dose of hallucinogenic drug psilocybin relieves anxiety and depression in patients with advanced cancer. New York, NY: New York University Langone Medical Center; December 1, 2016.

DR. THOMAS W. MILLER, PH.D, ABPP

Thomas W. Miller, Ph.D., ABPP, is a professor emeritus and senior research scientist, Center for Health, Intervention and Prevention, University of Connecticut; retired service chief from the VA Medical Center; and tenured professor in the Department of Psychiatry, College of Medicine, University of Kentucky.

more articles by Dr thomas w. miller